Cargando…

Comment on Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir(®) Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. Viruses 2022, 14, 525

Detalles Bibliográficos
Autor principal:	Alberts, Pēteris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506255/ https://www.ncbi.nlm.nih.gov/pubmed/36146882 http://dx.doi.org/10.3390/v14092076

Ejemplares similares

Reply to Alberts, P. Comment on “Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir(®) Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. Viruses 2022, 14, 525”
por: Hietanen, Eero, et al.
Publicado: (2022)

Cytolytic Properties and Genome Analysis of Rigvir(®) Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates
por: Hietanen, Eero, et al.
Publicado: (2022)

Genome Sequences of RIGVIR Oncolytic Virotherapy Virus and Five Other Echovirus 7 Isolates
por: Hietanen, Eero, et al.
Publicado: (2018)

Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study
por: Doniņa, Simona, et al.
Publicado: (2015)

Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines
por: Tilgase, Andra, et al.
Publicado: (2020)

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma
por: Babiker, Hani M, et al.
Publicado: (2017)

Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro
por: Tilgase, Andra, et al.
Publicado: (2018)

Comment on: Malfitano, A.M. et al. “Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer” Cancers 2019, 11, 1532
por: Alberts, Pēteris
Publicado: (2020)

Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report
por: Proboka, Guna, et al.
Publicado: (2018)

Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir
por: Proboka, Guna, et al.
Publicado: (2020)

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
por: Babiker, HM, et al.
Publicado: (2019)

Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report
por: Proboka, Guna, et al.
Publicado: (2019)

ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report
por: Jaunalksne, Inta, et al.
Publicado: (2020)

A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir(®)
por: Ismailov, Zaurbek, et al.
Publicado: (2019)

Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery
por: Tilgase, Andra, et al.
Publicado: (2018)

4-Week repeated dose rat GLP toxicity study of oncolytic ECHO-7 virus Rigvir administered intramuscularly with a 4-week recovery period
por: Piwoni, Katarzyna, et al.
Publicado: (2021)

Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(®) therapy: A case report
por: Pumpure, Elizabete, et al.
Publicado: (2020)

Comment on McCarthy, C.; et al. Developing Picornaviruses for Cancer Therapy. Cancers 2019, 11, 685
por: Alberts, Pēteris
Publicado: (2020)

Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Measles virus: Background and oncolytic virotherapy
por: Bhattacharjee, Sankhajit, et al.
Publicado: (2018)

Comment on van den Hurk et al. The Emergence of Japanese Encephalitis Virus in Australia in 2022: Existing Knowledge of Mosquito Vectors. Viruses 2022, 14, 1208
por: Brinkhoff, Michelle Nicole
Publicado: (2023)

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
por: Enow, Junior A., et al.
Publicado: (2023)

Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
por: Brokāne, Linda, et al.
Publicado: (2019)

Cytolytic replication of echoviruses in colon cancer cell lines
por: Israelsson, Stina, et al.
Publicado: (2011)

ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012)

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
por: Reale, Alberto, et al.
Publicado: (2021)

Oncolytic Sendai virus-based virotherapy for cancer: recent advances
por: Saga, Kotaro, et al.
Publicado: (2015)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
por: Yura, Yoshiaki
Publicado: (2017)

Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)

Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023)

Erratum: Melanoma Unknown Primary Brain Metastasis Treatment With ECHO-7 Oncolytic Virus Rigvir: A Case Report
Publicado: (2018)

Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report: Erratum
Publicado: (2019)

Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach
por: Mahasa, Khaphetsi Joseph, et al.
Publicado: (2017)

Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
por: Scheubeck, Gabriel, et al.
Publicado: (2019)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
por: Yin, Jie, et al.
Publicado: (2017)

TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy
por: Valenzuela-Cardenas, Miriam, et al.
Publicado: (2022)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Oncolytic virotherapy – in vivo veritas
por: Kemler, Iris, et al.
Publicado: (2018)

Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020)

Delivery and Biosafety of Oncolytic Virotherapy
por: Li, Lizhi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4d338j3cbd1slkv770b4g5738c